American Medical Association reverses position on chloroquine drugs

The American Medical Association (AMA) rescinded its previous statement which had called for physicians to stop prescribing hydroxychloroquine and chloroquine, reassured patients whose physicians are prescribing hydroxychloroquine and combination therapies for their early-stage COVID-19 diagnosis, and resolved to take actions necessary to require local pharmacies to fill valid prescriptions that are issued by physicians.

“Whereas, Data regarding harm have been limited due to poorly designed studies or studies usually in Stage 2 or later, or stopped without harm but no effect in phase 2 and hypothesis; and Whereas, There are many studies that indicate that the use of Hydroxychloroquine, Azithromycin is effective and front-line physicians are using the therapy where permissible? …See Resolution 509. November 2020.

https://www.ama-assn.org/system/files/2020-10/nov20-handbook-addendum.pdf

#healthcareindustry #covid19 #chloroquine #sarscov2 #hospitals #covid19news #Covid #pandemic2020

About budbromley

Bud is a retired life sciences executive. Bud's entrepreneurial leadership exceeded three decades. He was the senior business development, marketing and sales executive at four public corporations, each company a supplier of analytical and life sciences instrumentation, software, consumables and service. Prior to those positions, his 19 year career in Hewlett-Packard Company's Analytical Products Group included worldwide sales and marketing responsibility for Bioscience Products, Global Accounts and the International Olympic Committee, as well as international management assignments based in Japan and Latin America. Bud has visited and worked in more than 65 countries and lived and worked in 3 countries.

View all posts by budbromley →

This entry was posted in Uncategorized. Bookmark the permalink.